Prelude Capital Management, LLC Glycomimetics Inc Put Options Transaction History
Prelude Capital Management, LLC
- $1.5 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GLYC
# of Institutions
43Shares Held
30.3MCall Options Held
51KPut Options Held
1.4K-
Bvf Inc San Francisco, CA9.54MShares$3.15 Million0.09% of portfolio
-
Logos Global Management LP San Francisco, CA5.4MShares$1.78 Million0.18% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.09MShares$1.68 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3MShares$990,0000.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$881,1680.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $17.3M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...